Chemical.AI utilizes proprietary retrosynthesis algorithms and robotic lab automation to enhance chemical synthesis processes for pharmaceutical and chemical research. By integrating comprehensive chemical data, the platform improves productivity and reduces trial-and-error in drug discovery, enabling faster and more efficient development of new compounds.
Funding
$12.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Founders
Product
Problem
Developing new chemical compounds and drugs is often slowed by inefficient synthesis processes that rely on trial-and-error, extensive literature research, and difficulties in predicting reaction outcomes and potential impurities. Identifying viable synthesis routes and optimizing reaction conditions can be time-consuming and resource-intensive, hindering research productivity.
Solution
Chemical.AI offers ChemAIRS, a reaction informatics platform that leverages AI, comprehensive chemical data, and robotic lab automation to streamline chemical synthesis. The platform provides retrosynthesis design, condition optimization, impurity prediction, and forward synthesis capabilities, enabling researchers to accelerate the development of new compounds. By integrating advanced algorithms with a user-friendly interface, Chemical.AI enhances chemist productivity, reduces trial-and-error, and facilitates the integration of internal data to improve learning and reduce costs.
Target Audience
The primary customers are multinational pharmaceutical companies, small to mid-sized biotech firms, academic institutions, CROs, CDMOs, and CADD/AIDD companies involved in drug discovery, material science, and specialty chemicals.
Features
- AI-powered retrosynthesis planning that combines rule-based and generation-based approaches
- Synthesizability assessment to screen and rank compounds based on real-world feasibility
- Impurity prediction to identify potential byproducts early in the synthesis process
- Condition optimization to ensure cost-effective and scalable reactions
- High-throughput automation lab for synthesizing molecules at scale
- ChemAIOS system for streamlined lab management and error reduction
- User-friendly interface with real-time pricing and predictive route mapping